Compare Tata Nifty MidSmall Healthcare Index Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.27
2.3
NAV
₹14.16
₹311.14
Fund Started
08 Apr 2024
01 Aug 2005
Fund Size
₹163.78 Cr
₹1143.58 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year
17.14%
13.18%
3 Year
-
28.35%
5 Year
-
14.24%
Equity
100.08%
95.25%
Cash
-0.08%
4.74%
Top 10 Holdings
Lupin Ltd. | 9.88% |
Fortis Healthcare Ltd. | 8.50% |
Laurus Labs Ltd. | 7.57% |
Aurobindo Pharma Ltd. | 6.86% |
Glenmark Pharmaceuticals Ltd. | 6.40% |
Alkem Laboratories Ltd. | 5.58% |
Biocon Ltd. | 4.54% |
Mankind Pharma Ltd. | 4.49% |
Ipca Laboratories Ltd. | 3.76% |
Aster DM Healthcare Ltd. | 3.14% |
Sun Pharmaceutical Industries Ltd. | 9.49% |
Ajanta Pharma Ltd. | 5.84% |
Lupin Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.45% |
Glenmark Pharmaceuticals Ltd. | 3.35% |
Dr. Reddy's Laboratories Ltd. | 3.35% |
Gland Pharma Ltd. | 3.30% |
Fortis Healthcare Ltd. | 3.23% |
Alkem Laboratories Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
08 Apr 2024
01 Aug 2005
